Resiliency requirements vary across R&D labs, clinical trial suites, and full-scale manufacturing facilities. I compare how resiliency investments and risks differ across these pharmaceutical environments
Cras mattis, turpis nec sodales bibendum, erat ante mollis dui, at feugiat libero risus non risus. Donec tincidunt tortor id vestibulum pellentesque.
As manufacturers race to bring products to market faster, modular construction is becoming a strategic option for large facilities. In this video, Raymond Doyle explains how modular design can improve delivery timelines and why early evaluation is critical to maximizing project value.